Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

Phase II ABT-888 With Cyclophosphamide

NCT01306032

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +24 more
Locations
  • University of California, Davis Davis, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer

NCT01617668

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California at Los Angeles UCLA SC Los Angeles, California, United States
  • Stanford University Medical Center Stanford Stanford, California, United States
View all 50 locations
View Trial Details
Completed

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

NCT00022516

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Tweed Heads Hospital Tweed Heads, New South Wales, Australia
  • Queen Elizabeth Hospital Adelaide, South Australia, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Maroondah Hospital East Ringwood, Victoria, Australia
View all 36 locations
View Trial Details
Completed

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

NCT01173497

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +14 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • University of California At San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

NCT01677455

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Synta Pharmaceuticals Investigative Site Birmingham, Alabama, United States
  • Synta Pharmaceuticals Investigative Site Altanta, Georgia, United States
  • Synta Pharmaceuticals Investigative Site Boston, Massachusetts, United States
  • Synta Pharmaceuticals Investigative Site New York, United States
View all 25 locations
View Trial Details

Related conditions